Large size cells in the visceral adipose depot predict insulin resistance in the canine model

Obesity

Volumn 19, Issue 11, 2011, Pages 2121-2129

  Kabir, Morvarid ^a   Stefanovski, Darko ^a   Hsu, Isabel R ^a   Iyer, Malini ^a   Woolcott, Orison O ^a   Zheng, Dan ^a   Catalano, Karyn J ^a   Chiu, Jenny D ^a   Kim, Stella P ^a   Harrison, Lisa N ^a   Ionut, Viorica ^a   Lottati, Maya ^a   Bergman, Richard N ^a   Richey, Joyce M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIMONABANT;

ABDOMINAL OBESITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL SIZE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE MODEL; DOG; IMAGE ANALYSIS; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; LONGITUDINAL STUDY; MALE; MICROSCOPY; NONHUMAN; PREDICTION; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOSITY; ANIMALS; CELL SIZE; DIET, HIGH-FAT; DOGS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; MODELS, ANIMAL; OBESITY; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

ANIMALIA;

EID: 81155160893     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.254     Document Type: Article

References (38)

1. Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 1973;52:929-941.
2. Bergman RN. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes 2007;56:1489-1501. (Pubitemid 46842592)
3. Després JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med 2006;38:52-63.
4. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metab Clin Exp 1984;33:68-75. (Pubitemid 14224139)
5. McLaughlin T, Sherman A, Tsao P et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007;50:1707-1715. (Pubitemid 47036653)
6. Engfeldt P, Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl 1988;19:26-29. (Pubitemid 19005617)
7. Despres JP, Fong BS, Julien P, Jimenez J, Angel A. Regional variation in HDL metabolism in human fat cells: effect of cell size. Am J Physiol 1987;252:E654-E659.
8. Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, Eriksson JW. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007;50:625-633. (Pubitemid 46215507)
9. Molina JM, Ciaraldi TP, Brady D, Olefsky JM. Decreased activation rate of insulin-stimulated glucose transport in adipocytes from obese subjects. Diabetes 1989;38:991-995. (Pubitemid 20015049)
10. Matsubara Y, Kano K, Kondo D, Mugishima H, Matsumoto T. Differences in adipocytokines and fatty acid composition between two adipocyte fractions of small and large cells in high-fat diet-induced obese mice. Ann Nutr Metab 2009;54:258-267.
11. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-1033. (Pubitemid 46465679)
12. Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J. Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet 1972;2:948-951.
13. Kim SP, Catalano KJ, Hsu IR et al. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia. Am J Physiol Endocrinol Metab 2007;292:E1590-E1598. (Pubitemid 47084693)
14. Richey JM, Woolcott OO, Stefanovski D et al. Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs. Am J Physiol Endocrinol Metab 2009;296: E1311-E1318.
15. Richey JM. Woolcott O, Zheng D et al. Cannabinoid receptor antagonist rimonabant increases insulin sensitivity independent of weight loss. Diabetologia 2007 (suppl1), 50-0663.
16. Rodbell M. Metabolism of isolated fat cells. i. effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964;239:375-380.
17. Dole VP, Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 1960;235:2595-2599.
18. Kursawe R, Eszlinger M, Narayan D et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010;59:2288-2296.
19. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 1987;36:914-924. (Pubitemid 17136807)
20. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 2003;52:2453-2460. (Pubitemid 37210532)
21. Pasarica M, Tchoukalova YD, Heilbronn LK et al.; Look AHEAD Adipose Research Group. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) 2009;17:1976-1978.
22. Alkhouri N, Gornicka A, Berk MP et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 2010;285:3428-3438.
23. Bergman RN, Kim SP, Catalano KJ et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring) 2006;14 Suppl 1:16S-19S.
24. Pasarica M, Xie H, Hymel D et al. Lower total adipocyte number but no evidence for small adipocyte depletion in patients with type 2 diabetes. Diabetes Care 2009;32:900-902.
25. Gary-Bobo M, Elachouri G, Scatton B et al. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol 2006;69:471-478. (Pubitemid 43121944)
26. Bellocchio L, Cervino C, Vicennati V, Pasquali R, Pagotto U. Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. J Neuroendocrinol 2008;20 Suppl 1:130-138. (Pubitemid 351559286)
27. Hoffstedt J, Arner P, Hellers G, Lönnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 1997;38:795-804. (Pubitemid 27194930)
28. Cota D, Marsicano G, Tschöp M et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 2003;112:423-431. (Pubitemid 38063771)
29. Kabir M, Iyer M, Stefanovski D et al. Reduction of liver lipid accumulation by CB-1 antagonist is associated with an increase of adiponectin gene expression. Obesity 2008;14 (Suppl 1):OR-9.
30. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the antiinflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004;323:630-635. (Pubitemid 39221142)
31. Kissebah AH, Vydelingum N, Murray R et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260. (Pubitemid 12006594)
32. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162. (Pubitemid 14212633)
33. Barzilai N, She L, Liu BQ et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999;48:94-98. (Pubitemid 29019357)
34. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of longterm effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002;26:193-199. (Pubitemid 34151196)
35. Lottati M, Kolka CM, Stefanovski D, Kirkman EL, Bergman RN. Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity (Silver Spring) 2009;17:674-680.
36. Kabir M, Catalano KJ, Ananthnarayan S et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005;288:E454-E461. (Pubitemid 40110656)
37. Wueest S, Rapold RA, Rytka JM, Schoenle EJ, Konrad D. Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia 2009;52:541-546.
38. Guo W, Bigornia S, Leizerman I et al. New scanning electron microscopic method for determination of adipocyte size in humans and mice. Obesity (Silver Spring) 2007;15:1657-1665. (Pubitemid 47264944)